Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease

Advances in Medical Sciences

Volumn 56, Issue 2, 2011, Pages 255-263

  Bielecki, M ^a   Kowal, K ^a   Lapinska, A ^a   Chwiesko Minarowska, S ^a   Chyczewski, L ^a   Kowal Bielecka, O ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

angiogenesis; scleroderma; systemic sclerosis; vascular endothelial growth factor

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FORCED VITAL CAPACITY; HUMAN; LABORATORY TEST; LUNG CAPACITY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; SUPERNATANT; SYSTEMIC SCLEROSIS;

EID: 84855452428     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-011-0025-z     Document Type: Article

References (38)

1. Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii3-7.
2. Guiducci S, Distler O, Distler JH, Matucci-Cerinic M. Mechanisms of vascular damage in SSc-implications for vascular treatment strategies. Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v18-20.
3. Carpentier PH, Maricq HR. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am. 1990 Feb;16(1):75-91. (Pubitemid 20116146)
4. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000 Jan;27(1):155-60. (Pubitemid 30058643)
5. Koenig M. Joyal F,. Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senécal JL. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis. A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 2008 Dec;58(12):3902-12.
6. Chen ZY, Silver RM, Ainsworth SK, Dobson RL, Rust P, Maricq HR. Association between fuorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med. 1984 Nov;77(5):812-22. (Pubitemid 15204857)
7. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res. 2009 May;153(2):347-58.
8. Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay RE, Michel BA, Brühlmann P, Müller-Ladner U, Gay S, Matucci-Cerinic M. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fngertip ulcers. Arthritis Res. 2002;4(6):R11.
9. Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol. 2005 Apr;24(2):111-6. (Pubitemid 40552961)
10. Pendergrass SA, Hayes E, Farina G, Lemaire R, Farber HW, Whitfeld ML, Lafyatis R. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of infammation and vascular injury. PLoS One. 2010 Aug 17;5(8):e12106.
11. Solanilla A, Villeneuve J, Auguste P, Hugues M, Alioum A, Lepreux S, Ducroix JP, Duhaut P, Conri C, Viallard JF, Nurden AT, Constans J, Ripoche J. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis. Rheumatology (Oxford). 2009 Sep;48(9):1036-44.
12. Zhou B, Liu PX, Lan HF, Fang ZH, Han ZB, Ren H, Poon MC, Han ZC. Enhancement of neovascularization with mobilized blood cells transplantation: supply of angioblasts and angiogenic cytokines. J Cell Biochem. 2007 Sep 1;102(1):183-95. (Pubitemid 47378921)
13. Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y, Kojima H, Iwasaka T. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation. 2002 Oct 8;106(15):2019-25. (Pubitemid 35176311)
14. Li S, Zhou B, Han ZC. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34-mononuclear cells. Thromb Haemost. 2006 Feb;95(2):301-11.
15. Kamata Y, Takahashi Y, Iwamoto M, Matsui K, Murakami Y, Muroi K, Ikeda U, Shimada K, Yoshio T, Okazaki H, Minota S. Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases. Rheumatology (Oxford). 2007 May;46(5):882-4. (Pubitemid 47061726)
16. Takahashi M, Izawa A, Ishigatsubo Y, Fujimoto K, Miyamoto M, Horie T, Aizawa Y, Amano J, Minota S, Murohara T, Matsubara H, Ikeda U. Therapeutic neovascularization by the implantation of autologous mononuclear cells in patients with connective tissue diseases. Curr Pharm Des. 2009;15(24):2778-83.
17. Lafyatis R, York M. Innate immunity and infammation in systemic sclerosis. Curr Opin Rheumatol. 2009 Nov;21(6):617-22.
18. Bielecki M, Kowal K, Lapinska A, Chwiecko J, Skowronski J, Sierakowski S, Chyczewski L, Kowal-Bielecka O. Diminished production of TWEAK by the peripheral blood mononuclear cells is associated with vascular involvement in patients with systemic sclerosis. Folia Histochem Cytobiol. 2009 Jan:47(3):465-9.
19. Preliminary criteria for the classifcation of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980 May;23(5):581-90.
20. LeRoy EC, Medsger TA Jr. Criteria for the classifcation of early systemic sclerosis. J Rheumatol 2001 Jul;28(7):1573-6.
21. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classifcation, subsets and pathogenesis. J Rheumatol 1988 Feb;15(2):202-5. (Pubitemid 18073738)
22. Mukerjee D, St George D, Knight C, Davar J, Wells AU, Du Bois RM, Black CM, Coghlan JG. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004 Apr;43(4):461-6. (Pubitemid 38489363)
23. Maricq HR. Wide-feld capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum. 1981 Sep;24(9):1159-65. (Pubitemid 11057343)
24. Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, Michel BA, Gay RE, Müller-Ladner U, Matucci-Cerinic M, Plate KH, Gassmann M, Gay S. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insuffcient skin angiogenesis in patients with systemic sclerosis. Circ Res. 2004 Jul 9;95(1):109-16. (Pubitemid 38931842)
25. Davies CA, Jeziorska M, Freemont AJ, Herrick AL. The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis. Hum Pathol. 2006 Feb;37(2):190-7. (Pubitemid 43099839)
26. Mackiewicz Z, Sukura A, Povilenaité D, Ceponis A, Virtanen I, Hukkanen M, Konttinen YT. Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. Clin Exp Rheumatol. 2002 Sep-Oct;20(5):641-6. (Pubitemid 35243776)
27. Bottomley MJ, Webb NJ, Watson CJ, Holt PJ, Freemont AJ, Brenchley PE. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specifc up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fuid. Clin Exp Immunol. 1999 Jul;117(1):171-6. (Pubitemid 29292794)
28. Meliconi R, Pulsatelli L, Dolzani P, Boiardi L, Macchioni P, Salvarani C, Silvestri T, Frizziero L, Facchini A. Vascular endothelial growth factor production in polymyalgia rheumatica. Arthritis Rheum. 2000 Nov;43(11):2472-80.
29. Griga T, Gutzeit A, Sommerkamp C, May B. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with infammatory bowel disease. Eur J Gastroenterol Hepatol. 1999 Feb;11(2):175-9. (Pubitemid 29103579)
30. Hamamichi Y, Ichida F, Yu X, Hirono KI, Uese KI, Hashimoto I, Tsubata S, Yoshida T, Futatani T, Kanegane H, Miyawaki T. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr Res. 2001 Jan;49(1):74-80. (Pubitemid 32015003)
31. Sasaki Y, Kawamoto A, Iwano M, Kurioka H, Takase E, Kawata H, Tsujimura S, Fukuhara S, Akai Y, Hashimoto T, Dohi K. Vascular endothelial growth factor mRNA synthesis by peripheral blood mononuclear cells in patients with acute myocardial infarction. Int J Cardiol. 2001 Nov;81(1):51-60. (Pubitemid 33022661)
32. Salven P, Hattori K, Heissig B, Rafi S. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing infammatory cell VEGF synthesis and secretion. FASEB J. 2002 Sep;16(11):1471-3.
33. Drake CJ, Little CD. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci USA. 1995 Aug;92(17):7657-61.
34. Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ, Dvorak AM, Dvorak HF. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol. 2001 Mar;158(3):1145-60. (Pubitemid 32221807)
35. Konttinen YT, Mackiewicz Z, Ruuttila P, Ceponis A, Sukura A, Povilenaite D, Hukkanen M, Virtanen I. Vascular damage and lack of angiogenesis in systemic sclerosis skin. Clin Rheumatol. 2003 Sep;22(3):196-202. (Pubitemid 37258512)
36. Allanore Y, Borderie D, Airo P, Guiducci S, Czirják L, Nasonov EL, Riemekasten G, Caramaschi P, Majdan M, Krasowska D, Friedl E, Lemarechal H, Ananieva LP, Nievskaya T, Ekindjian OG, Matucci-Cerinic M, Kahan A. Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann Rheum Dis. 2007 Feb;66(2):257-9. (Pubitemid 46226065)
37. Winkles JA. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov. 2008 May;7(5):411-25 (Pubitemid 351619113)
38. Zheng TS, Burkly LC. No end in site: TWEAK/Fn14 activation and autoimmunity associated-end-organ pathologies. J Leukoc Biol. 2008 Aug;84(2):338-47.